MedTrace Logo

A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study

NCT01794468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2013-02-18

No results posted yet for this study

Summary

Background: Conditions of reduced perfusion are characterized by redistribution of blood flow away from the skin to more vital organs.

Study Objectives: To assess the efficacy of a non-invasive, dermal blood flow (DBF) monitor in detecting changes in perfusion in critically ill patients.

Preliminary Study

Study Population: critically ill patients in a general ICU

Conditions

  • Positive-Pressure Respiration, Intrinsic
  • Critically Ill Patients

Interventions

OTHER

Dermal blood flow measurements

Dermal blood flow was measured with the Dermal Blood Flow (DBF) monitor (I.S. MedTech, Israel), which consists of a skin probe and a measuring and control feedback unit.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Jonathan Cohen, Professor,MD · ICU dep't, Rabin MC,Petah Tikva, Israel

  • Pierre Singer, Professor,MD · ICU dep't, Rabin MC,Petah Tikva, Israel

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2005-04-30
Completion
2005-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01794468 on ClinicalTrials.gov